Century Therapeutics (IPSC) Other Accumulated Expenses (2022 - 2025)

Century Therapeutics (IPSC) has 4 years of Other Accumulated Expenses data on file, last reported at $1.0 million in Q3 2025.

• On a quarterly basis, Other Accumulated Expenses rose 1132.14% year-over-year to $1.0 million in Q3 2025; TTM through Sep 2025 was $1.0 million, a 1132.14% increase from a year earlier, with the FY2024 full-year figure at $75000.0, up 167.86% from the prior year.
• Other Accumulated Expenses for Q3 2025 stood at $1.0 million, up from $49000.0 in the prior quarter.
• Over the last five years, Other Accumulated Expenses for IPSC reached as high as $1.0 million in Q3 2025 and fell as low as $11000.0 in Q2 2023.
• Historically, Other Accumulated Expenses has averaged $164000.0 across 4 years, with a median of $75000.0 in 2024.
• Across the five-year window, Other Accumulated Expenses plunged 88.14% in 2023 and jumped 1132.14% in 2025, its largest moves.
• Year by year, Other Accumulated Expenses stood at $236000.0 in 2022, then plunged by 88.14% to $28000.0 in 2023, then jumped by 167.86% to $75000.0 in 2024, then jumped by 1280.0% to $1.0 million in 2025.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $1.0 million in Q3 2025, $49000.0 in Q2 2025, and $111000.0 in Q1 2025.